๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

State of the art in comparative cancer clinical trials

โœ Scribed by Colin B. Begg; Stuart J. Pocock; Laurence Freedman; Marvin Zelen


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
538 KB
Volume
60
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Predictors of enrollment in lung cancer
โœ Wei Du; Shirish M. Gadgeel; Michael S. Simon ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 77 KB

## Abstract ## BACKGROUND Clinical trials may offer patients innovative therapeutic options with potentially better outcomes, which are particularly relevant for patients afflicted with lung carcinoma, because current therapies provide only modest survival benefits. Only approximately 5% of patien

Randomized clinical trial comparing lapa
โœ J. Lujan; G. Valero; Q. Hernandez; A. Sanchez; M. D. Frutos; P. Parrilla ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 128 KB ๐Ÿ‘ 2 views

## Abstract ## Background The laparoscopic treatment of rectal cancer is controversial. This study compared surgical outcomes after laparoscopic and open approaches for mid and low rectal cancers. ## Methods Some 204 patients with mid and low rectal adenocarcinomas were allocated randomly to ope

Targeted therapy in head and neck cancer
โœ Corey J. Langer ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 174 KB ๐Ÿ‘ 2 views

## Abstract In patients with squamous cell carcinoma of the head and neck (SCCHN), tumor recurrence, secondary tumors, and comorbidities contribute to therapy failure, and treatment approaches often are limited by their toxicity. With the incorporation of targeted therapies, the number of options a